BIOC - .259 Pre-market now at .26/.289 Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer http://stockcharts.com/c-sc/sc?s=BIOC&p=D&b=5&g=0&i=t91718312718&r=1529325160724